Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Aug-24 4:06 PM View:  | Habig Scott Michael Chief Commercial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 06-Aug-24 | Sale | 18,249 | $5.31 | $96,902.20 | (4%) 474.59K to 456.34K | |
| 22-May-24 4:09 PM View: | Leversage Jill Director | Aurinia Pharmaceuticals Inc. (AUPH) | 21-May-24 | Sale | 5,610 | $5.74 | $32,201.40 | (30%) 18.53K to 12.92K | |
| 22-May-24 4:16 PM View: | Balakrishnan Brinda Director | Aurinia Pharmaceuticals Inc. (AUPH) | 21-May-24 | Sale | 520 | $5.74 | $2,984.80 | (3%) 18.04K to 17.52K | |
| 22-May-24 4:11 PM View: | Jayne David R.W. Director | Aurinia Pharmaceuticals Inc. (AUPH) | 21-May-24 | Sale | 4,946 | $5.74 | $28,390.00 | (10%) 49.31K to 44.36K | |
| 22-May-24 4:07 PM View: | MacKay-Dunn R. Hector Director | Aurinia Pharmaceuticals Inc. (AUPH) | 21-May-24 | Sale | 5,630 | $5.74 | $32,316.20 | (23%) 24.23K to 18.59K | |
| 22-May-24 4:14 PM View: | Billen Daniel Director | Aurinia Pharmaceuticals Inc. (AUPH) | 21-May-24 | Sale | 5,252 | $5.74 | $30,146.50 | (16%) 33.39K to 28.14K | |
| 07-Mar-24 4:44 PM View: | Miller Joseph M Chief Financial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 06-Mar-24 | Sale | 34,811 | $5.60 | $194,942.00 | (7%) 530.74K to 495.93K | |
| 07-Mar-24 4:43 PM View: | Donley Matthew Maxwell EVP, Ops & Strategy | Aurinia Pharmaceuticals Inc. (AUPH) | 06-Mar-24 | Sale | 40,665 | $5.51 | $224,064.00 | (7%) 624.74K to 584.07K | |
| 07-Mar-24 4:41 PM View: | Robertson Stephen P. EVP, General Counsel | Aurinia Pharmaceuticals Inc. (AUPH) | 06-Mar-24 | Sale | 57,745 | $5.60 | $323,372.00 | (12%) 501.57K to 443.82K | |
| 07-Mar-24 4:42 PM View: | Habig Scott Michael Chief Commercial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 06-Mar-24 | Sale | 17,777 | $5.60 | $99,551.20 | (4%) 492.36K to 474.59K | |
| 07-Mar-24 4:46 PM View: | Greenleaf Peter Chief Executive Officer Director | Aurinia Pharmaceuticals Inc. (AUPH) | 06-Mar-24 | Sale | 126,981 | $5.60 | $711,094.00 | (8%) 1.65M to 1.52M | |
| 29-Feb-24 4:11 PM View: | Knappertz Volker EVP, Research and Development | Aurinia Pharmaceuticals Inc. (AUPH) | 27-Feb-24 | Sale | 4,930 | $6.10 | $30,073.00 | (2%) 324.06K to 319.13K | |
| 22-Feb-24 4:33 PM View: | Habig Scott Michael Chief Commercial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Grant | 195,512 | -- | -- | 63% 312.72K to 508.23K | |
| 22-Feb-24 4:31 PM View: | Donley Matthew Maxwell EVP, Ops & Strategy | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Grant | 216,666 | -- | -- | 53% 408.07K to 624.74K | |
| 22-Feb-24 4:29 PM View: | Robertson Stephen P. EVP, General Counsel | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Grant | 194,230 | -- | -- | 63% 307.34K to 501.57K | |
| 22-Feb-24 4:33 PM View: | Habig Scott Michael Chief Commercial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Sale | 15,867 | $5.48 | $86,951.20 | (3%) 508.23K to 492.36K | |
| 22-Feb-24 4:25 PM View: | Greenleaf Peter Chief Executive Officer Director | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Grant | 661,538 | -- | -- | 67% 987.56K to 1.65M | |
| 22-Feb-24 4:35 PM View: | Knappertz Volker EVP, Research and Development | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Sale | 25,146 | $5.48 | $137,800.00 | (7%) 349.2K to 324.06K | |
| 22-Feb-24 4:27 PM View: | Miller Joseph M Chief Financial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Grant | 196,153 | -- | -- | 59% 334.59K to 530.74K | |
| 23-May-23 5:19 PM View: | Jayne David R.W. Director | Aurinia Pharmaceuticals Inc. (AUPH) | 23-May-23 | Option Sale | 8,733 | $11.26 | $98,333.60 | (15%) 58.04K to 49.31K | |
| 23-May-23 5:16 PM View: | MacKay-Dunn R. Hector Director | Aurinia Pharmaceuticals Inc. (AUPH) | 23-May-23 | Option Sale | 4,818 | $11.26 | $54,250.70 | (17%) 29.04K to 24.23K | |
| 23-May-23 5:17 PM View: | Billen Daniel Director | Aurinia Pharmaceuticals Inc. (AUPH) | 23-May-23 | Option Sale | 4,650 | $11.26 | $52,359.00 | (12%) 38.04K to 33.39K | |
| 23-May-23 5:14 PM View: | Leversage Jill Director | Aurinia Pharmaceuticals Inc. (AUPH) | 23-May-23 | Option Sale | 4,815 | $11.26 | $54,216.90 | (21%) 23.34K to 18.53K | |
| 23-May-23 5:14 PM View: | Leversage Jill Director | Aurinia Pharmaceuticals Inc. (AUPH) | 19-May-23 | Grant | 9,310 | -- | -- | 66% 14.03K to 23.34K | |
| 23-May-23 5:18 PM View: | Hagan Joseph P Director | Aurinia Pharmaceuticals Inc. (AUPH) | 19-May-23 | Option Sale | 272 | $10.58 | $2,877.76 | (2%) 12.23K to 11.96K | |
| 23-May-23 5:19 PM View: | Jayne David R.W. Director | Aurinia Pharmaceuticals Inc. (AUPH) | 19-May-23 | Grant | 9,310 | -- | -- | 19% 48.73K to 58.04K | |
| 23-May-23 5:16 PM View: | MacKay-Dunn R. Hector Director | Aurinia Pharmaceuticals Inc. (AUPH) | 19-May-23 | Grant | 9,310 | -- | -- | 47% 19.73K to 29.04K | |
| 23-May-23 5:22 PM View: | Balakrishnan Brinda Director | Aurinia Pharmaceuticals Inc. (AUPH) | 19-May-23 | Grant | 9,310 | -- | -- | 107% 8.73K to 18.04K | |
| 23-May-23 5:17 PM View: | Billen Daniel Director | Aurinia Pharmaceuticals Inc. (AUPH) | 19-May-23 | Grant | 9,310 | -- | -- | 32% 28.73K to 38.04K | |
| 23-May-23 5:18 PM View: | Hagan Joseph P Director | Aurinia Pharmaceuticals Inc. (AUPH) | 18-May-23 | Option Exercise | 8,733 | -- | -- | 250% 3.5K to 12.23K | |
| 23-May-23 5:17 PM View: | Billen Daniel Director | Aurinia Pharmaceuticals Inc. (AUPH) | 18-May-23 | Option Exercise | 8,733 | -- | -- | 44% 20.0K to 28.73K | |
| 23-May-23 5:16 PM View: | Milne George M Jr Director | Aurinia Pharmaceuticals Inc. (AUPH) | 18-May-23 | Option Exercise | 8,733 | -- | -- | 12% 70.0K to 78.73K | |
| 23-May-23 5:14 PM View: | Leversage Jill Director | Aurinia Pharmaceuticals Inc. (AUPH) | 18-May-23 | Option Exercise | 8,733 | -- | -- | 165% 5.3K to 14.03K | |
| 23-May-23 5:19 PM View: | Jayne David R.W. Director | Aurinia Pharmaceuticals Inc. (AUPH) | 18-May-23 | Option Exercise | 8,733 | -- | -- | 22% 40.0K to 48.73K | |
| 23-May-23 5:16 PM View: | MacKay-Dunn R. Hector Director | Aurinia Pharmaceuticals Inc. (AUPH) | 18-May-23 | Option Exercise | 8,733 | -- | -- | 79% 11.0K to 19.73K | |
| 23-May-23 5:22 PM View: | Balakrishnan Brinda Director | Aurinia Pharmaceuticals Inc. (AUPH) | 18-May-23 | Option Exercise | 8,733 | -- | -- | 100% 0 to 8.73K | |
| 06-Mar-23 4:29 PM View: | Robertson Stephen P. EVP, General Counsel | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Sale | 19,402 | $8.94 | $173,454.00 | (6%) 322.77K to 303.36K | |
| 06-Mar-23 4:29 PM View: | Miller Joseph M Chief Financial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 229,421 | -- | -- | 203% 113.09K to 342.51K | |
| 06-Mar-23 4:27 PM View: | Greenleaf Peter Chief Executive Officer Director | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Sale | 32,750 | $8.94 | $292,785.00 | (3%) 1.02M to 982.97K | |
| 06-Mar-23 4:28 PM View: | Knappertz Volker EVP, Research and Development | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 191,462 | -- | -- | 125% 152.81K to 344.27K | |
| 06-Mar-23 4:29 PM View: | Miller Joseph M Chief Financial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Sale | 11,296 | $8.94 | $100,986.00 | (3%) 342.51K to 331.21K | |
| 06-Mar-23 4:29 PM View: | Milne George M Jr Director | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Private Purchase | 20,000 | $8.91 | $178,284.00 | 40% 50.0K to 70.0K | |
| 06-Mar-23 4:29 PM View: | Robertson Stephen P. EVP, General Counsel | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 204,810 | -- | -- | 174% 117.96K to 322.77K | |
| 06-Mar-23 4:28 PM View: | Habig Scott Michael Chief Commercial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 170,188 | -- | -- | 119% 142.53K to 312.72K | |
| 06-Mar-23 4:29 PM View: | Donley Matthew Maxwell EVP, Ops & Strategy | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 271,134 | -- | -- | 205% 132.01K to 403.14K | |
| 06-Mar-23 4:28 PM View: | Martin Michael Robert Chief Business Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 107,202 | -- | -- | 71% 151.96K to 259.16K | |
| 06-Mar-23 4:27 PM View: | Greenleaf Peter Chief Executive Officer Director | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 667,407 | -- | -- | 192% 348.31K to 1.02M | |
| 23-Nov-22 4:04 PM View: | Donley Matthew Maxwell Ex VP, Internal Operations | Aurinia Pharmaceuticals Inc. (AUPH) | 21-Nov-22 | Private Purchase | 10,000 | $4.66 | $46,600.00 | 56% 17.93K to 27.93K | |
| 14-Nov-22 4:31 PM View: | Habig Scott Michael Chief Commercial Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 09-Nov-22 | Private Purchase | 5,000 | $5.01 | $25,075.00 | 100% 0 to 5.0K | |
| 09-Nov-22 4:05 PM View: | Martin Michael Robert Chief Business Officer | Aurinia Pharmaceuticals Inc. (AUPH) | 07-Nov-22 | Private Purchase | 30,000 | $5.16 | $154,800.00 | 50% 59.51K to 89.51K |
